New Delhi, Delhi, India | 28th July 2025:
India Accelerates Biomedical Innovation with Inaugural i3 Summit – Vimarsh by Blockchain For Impact
India’s biomedical research and development (R&D) sector is witnessing a transformative phase, driven by strategic government initiatives and increased investment in scientific innovation. With a renewed focus on advancing translational research and bridging the gap between laboratory breakthroughs and real-world solutions, India is poised to become a global hub for biomedical innovation.
Despite enduring challenges such as limited private sector participation and slow commercialization of research, the momentum for a thriving R&D ecosystem is stronger than ever. Recognizing the need to mobilize talent, inspire scientific leadership, and foster collaboration, Blockchain For Impact (BFI) has launched a pioneering platform—i3 Summit – Vimarsh.
Introducing i3 Summit – Vimarsh: A Conclave for Scientific and Biomedical Innovation
Set to redefine the landscape of scientific collaboration in India, the i3 Summit – Vimarsh is the country’s premier conclave dedicated to advancing biomedical research, healthcare innovation, and science-driven entrepreneurship. Spearheaded by Blockchain For Impact (BFI), the event reflects a deep commitment to empowering India’s brightest minds.
The summit will be inaugurated by Padma Shri Dr. Balram Bhargava, celebrated for leading the development of the indigenous COVAXIN vaccine, and will feature Hon’ble Shri Nitin Gadkari, Union Minister of Road Transport & Highways, as Chief Guest.
“The i3 Summit – Vimarsh represents a vital confluence for India’s brightest minds. It is through platforms such as this, where collective intellect and shared purpose converge, that we will accelerate our nation’s progress in medical research and innovation,” said Dr. Bhargava.
Driving Scientific Innovation Through Blockchain For Impact (BFI)
Founded during India’s second COVID wave, Blockchain For Impact (BFI) is now one of the country’s most transparent and mission-driven healthcare organizations. Initially focused on crisis relief, BFI has since transitioned to long-term impact through biomedical R&D and innovation.
At the heart of this transition is the BFI-BIOME Virtual Network, a unique initiative designed to unify research institutions, medical incubators, biotech firms, and industry leaders under one collaborative platform. The goal: to drive translational biomedical research that leads to actionable solutions in diagnostics, medical devices, therapeutics, and public health.
“I am deeply committed to promoting ease of scientific research and biomedical innovation in India,” said Sandeep Nailwal, Philanthropist, Founder of BFI, and Co-founder & CEO of the Polygon Foundation. “The i3 Summit is my sincere effort to foster collaboration among India’s top scientific minds and build a future-ready healthcare ecosystem.”
Shaping the Future of Healthcare Through Collaboration and Innovation
With an unwavering focus on inclusivity and equity, BFI aims to improve the well-being of marginalized communities while solving critical healthcare challenges. Through initiatives like i3 Summit – Vimarsh and the BFI-BIOME Network, BFI is building the foundation for a resilient, innovation-led healthcare system.
As India scales new heights in science and biomedical technology, conclaves like the i3 Summit mark a turning point—creating a collaborative, cross-sectoral movement toward future-ready, equitable healthcare innovation.
